Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 26,776 shares at $70.14 ($1.9M) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Scheduled sale ($1.9M) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.14 | 13,388 | $939K | 50.0% |
| 2 | $70.14 | 13,388 | $939K | 50.0% |
| Total | $70.14 avg | 26,776 | $1.9M | 100% |
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |